<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01213524</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA014002</org_study_id>
    <nct_id>NCT01213524</nct_id>
  </id_info>
  <brief_title>Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia</brief_title>
  <official_title>Biological and Behavioral Mechanisms of Smoking in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Brown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to investigate the relative contributions of nicotine
      replacement and sensorimotor replacement (i.e., smoking denicotinized cigarettes) on
      abstinence-induced smoking urges, withdrawal-related negative affect, psychiatric symptoms,
      cognitive task performance and smoking behavior in smokers with schizophrenia and
      non-psychiatric smokers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>preferred brand smoking</measure>
    <time_frame>90 min</time_frame>
    <description>preferred brand smoking is measured after 5-hr &quot;satiation&quot; periods in which nicotine replacement and/or sensorimotor replacement are provided under double-blind conditions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cigarette craving</measure>
    <time_frame>5 hr</time_frame>
    <description>cigarette craving is measured after 5-hr &quot;satiation&quot; period in which nicotine replacement and/or sensorimotor replacement for smoking are provided under double-blind conditions</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Active NRT + denicotinized cigarettes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>42 mg nicotine replacement plus sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo NRT + denicotinized cigarettes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>inactive transdermal patches plus sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active NRT + no cigarettes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>42 mg nicotine replacement with no sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo NRT + No cigarettes</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Double placebo: No nicotine or sensorimotor replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual brand smoking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>positive control: usual brand smoking</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>sensorimotor replacement</intervention_name>
    <description>denicotinized cigarettes</description>
    <arm_group_label>Active NRT + denicotinized cigarettes</arm_group_label>
    <arm_group_label>Placebo NRT + denicotinized cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>42 mg transdermal nicotine replacement</intervention_name>
    <description>2 21-mg nicotine patches</description>
    <arm_group_label>Active NRT + denicotinized cigarettes</arm_group_label>
    <arm_group_label>Active NRT + no cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo transdermal nicotine</intervention_name>
    <description>2 placebo patches matched to 21-mg nicotine patches</description>
    <arm_group_label>Placebo NRT + denicotinized cigarettes</arm_group_label>
    <arm_group_label>Placebo NRT + No cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual brand smoking</intervention_name>
    <description>participant smokes usual brand of cigarette</description>
    <arm_group_label>usual brand smoking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  schizophrenia or no psychiatric illness

          -  18 and older

          -  men and women

          -  cigarette smokers, 20-50 cigarettes per day

          -  would like to quit someday

        Exclusion Criteria:

          -  medical conditions excluding transdermal nicotine replacement

          -  pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Tidey, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brown University, 121 South Main Street</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2010</study_first_submitted>
  <study_first_submitted_qc>October 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2010</study_first_posted>
  <last_update_submitted>July 26, 2012</last_update_submitted>
  <last_update_submitted_qc>July 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brown University</investigator_affiliation>
    <investigator_full_name>Jennifer Tidey</investigator_full_name>
    <investigator_title>Associate Professor (Research)</investigator_title>
  </responsible_party>
  <keyword>nicotine</keyword>
  <keyword>craving</keyword>
  <keyword>dual-diagnosis</keyword>
  <keyword>comorbidity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 19, 2012</submitted>
    <returned>December 17, 2012</returned>
    <submitted>February 4, 2013</submitted>
    <returned>March 12, 2013</returned>
    <submitted>March 13, 2013</submitted>
    <returned>April 24, 2013</returned>
    <submitted>July 1, 2013</submitted>
    <returned>August 2, 2013</returned>
    <submitted>October 5, 2015</submitted>
    <returned>November 4, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

